Opus Genetics is a pharmaceutical preparations company trading on XNAS, led by CEO George Magrath, with a market cap of $332.9M.
Based on Q4 2025 filing
Common questions about Opus Genetics
Opus Genetics (IRD) has a market capitalization of $332.9M and trades on XNAS.
Opus Genetics has approximately 14 employees.